SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Clemens Scheinecker, Blockade of co-stimulation in chronic inflammatory diseases, Wiener Medizinische Wochenschrift, 2015, 165, 1-2, 23

    CrossRef

  2. 2
    Josef S. Smolen, Daniel Aletaha, Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges, Nature Reviews Rheumatology, 2015,

    CrossRef

  3. 3
    Martin Aringer, Josef S Smolen, Safety of off-label biologicals in systemic lupus erythematosus, Expert Opinion on Drug Safety, 2015, 14, 2, 243

    CrossRef

  4. 4
    A. Picchianti Diamanti, M. M. Rosado, M. Scarsella, V. Germano, E. Giorda, S. Cascioli, B. Laganà, R. D'Amelio, R. Carsetti, Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents, Clinical & Experimental Immunology, 2014, 177, 3
  5. 5
    Fabio E. Ospina, Andrés Agualimpia, Fabio Bonilla-Abadía, Carlos A. Cañas, Gabriel J. Tobón, Pneumocystis jiroveciiPneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept, Case Reports in Rheumatology, 2014, 2014, 1

    CrossRef

  6. 6
    Damian Maseda, Rachel H Bonami, Leslie J Crofford, Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis, Expert Review of Clinical Immunology, 2014, 10, 6, 747

    CrossRef

  7. 7
    Mariana H García-Hernández, Roberto González-Amaro, Diana Patricia Portales-Pérez, Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects, Immunotherapy, 2014, 6, 5, 623

    CrossRef

  8. 8
    D. Aeberli, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  9. 9
    Gillian M. Keating, Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis, Drugs, 2013, 73, 10, 1095

    CrossRef